Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E González

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Revista De Neurologia|October 29, 2002
[Bioethical considerations of genetic engineering]M E González-Fraguela
Virology|January 9, 2001
Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilizationM E González, L Carrasco
Biochemical and Biophysical Research Communications|August 14, 1987
Animal viruses promote the entry of polysaccharides with antiviral activity into cellsM E González, L Carrasco
Biochemistry|September 30, 1998
The human immunodeficiency virus type 1 Vpu protein enhances membrane permeabilityM E González, L Carrasco
Revista De Neurologia|November 6, 1998
[Genetic therapy for the nervous system: a trend in modern neurology]M González-Hoyuela, M E González-Fraguela
Journal of Molecular Biology|October 11, 1996
Human immunodeficiency virus (HIV) Nef is an RNA binding protein in cell-free systemsA Echarri, M E González, L Carrasco
FEBS Letters|April 11, 1988
Megalomycin C, a macrolide antibiotic that blocks protein glycosylation and shows antiviral activityB Alarcón, M E González, L Carrasco
European Journal of Biochemistry|May 15, 1997
The N-terminal Arg-rich region of human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef is involved in RNA bindingA Echarri, M E González, L Carrasco
Antimicrobial Agents and Chemotherapy|November 1, 1984
Antiherpesvirus action of atropineB Alarcón, M E González, L Carrasco
Antimicrobial Agents and Chemotherapy|September 1, 1987
Polysaccharides as antiviral agents: antiviral activity of carrageenanM E González, B Alarcón, L Carrasco
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Revista De Neurologia|October 29, 2002
[Bioethical considerations of genetic engineering]M E González-Fraguela
Virology|January 9, 2001
Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilizationM E González, L Carrasco
Biochemical and Biophysical Research Communications|August 14, 1987
Animal viruses promote the entry of polysaccharides with antiviral activity into cellsM E González, L Carrasco
Biochemistry|September 30, 1998
The human immunodeficiency virus type 1 Vpu protein enhances membrane permeabilityM E González, L Carrasco
Revista De Neurologia|November 6, 1998
[Genetic therapy for the nervous system: a trend in modern neurology]M González-Hoyuela, M E González-Fraguela
Journal of Molecular Biology|October 11, 1996
Human immunodeficiency virus (HIV) Nef is an RNA binding protein in cell-free systemsA Echarri, M E González, L Carrasco
FEBS Letters|April 11, 1988
Megalomycin C, a macrolide antibiotic that blocks protein glycosylation and shows antiviral activityB Alarcón, M E González, L Carrasco
European Journal of Biochemistry|May 15, 1997
The N-terminal Arg-rich region of human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef is involved in RNA bindingA Echarri, M E González, L Carrasco
Antimicrobial Agents and Chemotherapy|November 1, 1984
Antiherpesvirus action of atropineB Alarcón, M E González, L Carrasco
Antimicrobial Agents and Chemotherapy|September 1, 1987
Polysaccharides as antiviral agents: antiviral activity of carrageenanM E González, B Alarcón, L Carrasco
Pageof 11